Phase II feasibility trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node-positive breast cancer: A trial of the Eastern Cooperative Oncology Group (E2104) Meeting Abstract
| Authors: | Miller, K. D.; O'Neill, A.; Perez, E. A.; Seidman, A. D.; Sledge, G. W. |
| Abstract Title: | Phase II feasibility trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node-positive breast cancer: A trial of the Eastern Cooperative Oncology Group (E2104) |
| Meeting Title: | 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2008 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-05-20 |
| Start Page: | 11s |
| Language: | English |
| ACCESSION: | WOS:000208457400157 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2008.26.15_suppl.520 |
| Notes: | Meeting Abstract: 520 -- Source: Wos |
